NanJing Pharmaceutical Co Ltd Financial Flexibility Index
NanJing Pharmaceutical Co Ltd financial flexibility index. NanJing Pharmaceutical Co Ltd (600713) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of CN¥-906.23 Million (operating CF CN¥-942.93 Million minus capex CN¥36.70 Million) represents 0% of total liabilities (CN¥26.09 Billion). See NanJing Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NanJing Pharmaceutical Co Ltd (1998–2024)
Financial flexibility index of NanJing Pharmaceutical Co Ltd from 1998 to 2024. Historical Financial Flexibility Index trend for NanJing Pharmaceutical Co Ltd across 27 annual periods. Check NanJing Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
NanJing Pharmaceutical Co Ltd Financial Flexibility Index by Year (1998–2024)
NanJing Pharmaceutical Co Ltd financial flexibility index by year from 1998 to 2024. Year-by-year free cash flow to debt coverage for NanJing Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600713 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥2.68 Billion | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +20.0% |
| 2023 | 0.10x | CN¥2.06 Billion | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +562.1% |
| 2022 | -0.02x | CN¥-527.03 Million | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -143.5% |
| 2021 | 0.05x | CN¥1.00 Billion | CN¥695.33 Million | CN¥20.65 Billion | ▲ +199.6% |
| 2020 | -0.05x | CN¥-905.49 Million | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -165.1% |
| 2019 | 0.07x | CN¥1.30 Billion | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +2185.7% |
| 2018 | 0.00x | CN¥-55.38 Million | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -108.1% |
| 2017 | 0.04x | CN¥560.56 Million | CN¥319.99 Million | CN¥12.74 Billion | ▲ +1164.3% |
| 2016 | 0.00x | CN¥-45.03 Million | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +70.7% |
| 2015 | -0.01x | CN¥-139.73 Million | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +33.6% |
| 2014 | -0.02x | CN¥-189.67 Million | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +7.6% |
| 2013 | -0.02x | CN¥-192.26 Million | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -141.5% |
| 2012 | 0.06x | CN¥438.89 Million | CN¥168.17 Million | CN¥7.91 Billion | ▲ +267.3% |
| 2011 | -0.03x | CN¥-254.15 Million | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -159.9% |
| 2010 | 0.06x | CN¥393.58 Million | CN¥119.08 Million | CN¥7.11 Billion | ▲ +91.1% |
| 2009 | 0.03x | CN¥167.19 Million | CN¥20.22 Million | CN¥5.77 Billion | ▲ +5.7% |
| 2008 | 0.03x | CN¥121.44 Million | CN¥4.33 Million | CN¥4.43 Billion | ▼ -28.9% |
| 2007 | 0.04x | CN¥165.50 Million | CN¥81.08 Million | CN¥4.30 Billion | ▼ -41.9% |
| 2006 | 0.07x | CN¥201.70 Million | CN¥161.31 Million | CN¥3.04 Billion | ▼ -17.5% |
| 2005 | 0.08x | CN¥215.37 Million | CN¥165.57 Million | CN¥2.68 Billion | ▲ +73.0% |
| 2004 | 0.05x | CN¥116.98 Million | CN¥16.26 Million | CN¥2.52 Billion | ▲ +0.6% |
| 2003 | 0.05x | CN¥93.17 Million | CN¥19.27 Million | CN¥2.02 Billion | ▼ -77.2% |
| 2002 | 0.20x | CN¥266.02 Million | CN¥68.75 Million | CN¥1.31 Billion | ▲ +244.0% |
| 2001 | 0.06x | CN¥41.17 Million | CN¥-4.20 Million | CN¥697.93 Million | ▼ -61.9% |
| 2000 | 0.16x | CN¥115.07 Million | CN¥87.68 Million | CN¥742.31 Million | ▲ +0.1% |
| 1999 | 0.15x | CN¥77.64 Million | CN¥50.58 Million | CN¥501.56 Million | ▼ -55.7% |
| 1998 | 0.35x | CN¥153.84 Million | CN¥77.45 Million | CN¥440.31 Million | — |